James Lim, MD
Family Medicine · Irwin, PANPI 1326167883
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $156,800 of the $210,414 with a category attached, or 74.5%. Braeburn Inc. accounts for 88.8% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $114,820, 9.9 times the $11,651 reported in 2019. Among family medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 555 payments — averaging $379.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$187K
- Indivior Inc.$19K
- AbbVie$910
- Pear Therapeutics (US), Inc.$648
- Novo Nordisk$615
- Takeda Pharmaceuticals U.S.A., Inc.$195
- plus $2K from 35 others
What the payments were for
- Consulting fees$1,6201%
- Speaking & faculty fees$156,80075%
- Travel & lodging$41,56420%
- Food & beverage$9,7265%
- Education$7040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$210,414 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 42 | $43,269 |
| SublocadeBuprenorphine | 19 | $38,362 |
| BrixadiBuprenorphine | 17 | $19,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $19,189 |
| VivitrolNaltrexone Microspheres | 12 | $18,809 |
| EliquisApixaban | 18 | $16,847 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 43 | $2,243 |
| Gabapentin | 94 | $1,176 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,079 |
| Atorvastatin Calcium | 119 | $831 |
| Pantoprazole Sodium | 101 | $759 |
| Levothyroxine Sodium | 76 | $699 |
| Metoprolol Succinate | 55 | $610 |
| Duloxetine Hcl | 24 | $557 |
| Tamsulosin Hcl | 37 | $463 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $96 | $43,26942 claims |
| Indivior Inc.Sublocade | $19,376 | $38,36219 claims |
| Braeburn Inc.Brixadi | $186,799 | $19,66617 claims |
| GSKTrelegy Ellipta | $158 | $19,18925 claims |
| Alkermes, Inc.Vivitrol | $74 | $18,80912 claims |
| PfizerEliquis | $162 | $16,84718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Irwin
- Mary ZakutneyIrwin$393K
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.